Close
ACHEMA MIDDLE EAST 2026

Biosimilars Can End Up Drawing A Large Amount of Savings

According to the AHIP report, savings from biosimilars are assumed to exceed $180 billion over the next five years, representing a four-fold increase over...

Sustained Release Chemotherapy, A Way Out For Bladder Cancer

As reported by a study, a novel, sustained-release chemotherapy delivery device which is inserted in the bladder has gone on to facilitate the tumour...

The Ever-Thriving Pharma Cold Chain Logistics In Europe

In December, the European Commission went on to issue the first approval when it comes to allogenic T-cell therapy in the world, which happened...

Pharma Supply Chain Present Danger As Drug Shortages Rise

Drug shortages endanger national security as well as public health. This is the conclusion of a new report from the United States Senate's Homeland...

World Cell & Gene Therapy Supply Chain To Hit $3.12b By 2031

The global cell and gene therapy (CGT) supply chain and logistics industry is predicted to reach $3.12 billion by 2031, based on a market...

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within...

Australia Sepsis Study To Aid In New Antibiotic Discovery

Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...